Optimata Ltd. to Present Virtual Patient That Predicts Response to Cancer Drugs at UK Conference
RAMAT GAN, Israel & LONDON--(BUSINESS WIRE)--Optimata Ltd., developer of the OPTIMATA VIRTUAL PATIENT® proprietary modeling technology for drug development and personalized medicine, today announced that Prof. Zvia Agur, Founder and CSO, has been invited to speak at the “Speed and Safety in Drug Discovery” conference to be held at the Royal Society, London, on November 26, 2008.